New study pits light therapy against pill for vitiligo
NCT ID NCT07055529
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study compares two treatments for generalized vitiligo, a condition causing white patches on the skin. Researchers will test PUVA (a light therapy) against tofacitinib (a pill) in 64 adults aged 18-60. The goal is to see which treatment restores more skin color over six months, with a focus on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO, GENERALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MTI-HMC Peshawar
Peshawar, Khyber Pukhtunkhwa, 25000, Pakistan
Conditions
Explore the condition pages connected to this study.